Premarket trading on Friday offered a mixed picture for the stocks most discussed on the WallStreetBets forum. SpaceX and a handful of chipmakers edged higher, while Moderna extended its slide after reports of a data leak linked to its melanoma vaccine partnership with Merck.
The divergence highlights how quickly sentiment can shift among retail traders, especially after a volatile session. Premarket moves are often treated as a rough gauge of investor mood, but they can be noisy and don't always predict how stocks will close.
What moved before the bell
SpaceX was up about 2.4% in premarket trading, a partial rebound after a 9.1% drop on Thursday. The company has been in the spotlight recently, with reports about its plans to build a fourth wireless carrier and its ongoing review of a potential Tesla tie-up. Those developments have kept the stock volatile, and Friday's bounce suggests some traders saw the previous day's decline as an opportunity.
Chipmakers also steadied. Micron gained 1.8% premarket after falling 6.3% on Thursday, while Nvidia rose 0.5% following a 4.4% decline. Both companies are central to the AI trade, and their recent swings reflect broader uncertainty about AI-related spending and valuations. Micron has also been in the news for tying executive bonuses to profitability and capital spending, a move that some analysts see as a sign of discipline in a cyclical industry.
Moderna moved in the opposite direction, dropping another 4.5% premarket after a 17.6% slide on Thursday. The decline follows reports of a data leak tied to its melanoma vaccine program with Merck. The vaccine, which is being developed to treat melanoma, is one of Moderna's most promising pipeline candidates, so any setback is closely watched by investors.
Why premarket moves matter (and why they don't)
Premarket trading is a window into how investors are positioning before the regular session opens. It's especially useful after a big move, because it shows whether traders are trying to catch a falling knife or lock in gains. But it's also a thin market, with lower liquidity and wider spreads, so prices can be misleading.
For everyday investors, the key takeaway is that premarket action is just one data point. It doesn't replace a careful look at a company's fundamentals, competitive position, or the broader economic backdrop. A stock that bounces premarket can still close lower, and vice versa.
What it means for investors
For those following the WallStreetBets crowd, Friday's split is a reminder that even the most popular stocks can move in different directions based on company-specific news. SpaceX's rebound suggests that traders are still willing to buy dips in names with strong narratives, but the volatility cuts both ways.
Moderna's slide underscores the risks of investing in biotech, where a single piece of news—like a data leak—can wipe out billions in market value. The melanoma vaccine with Merck is a high-stakes program, and any perceived setback can spook investors, even if the long-term outlook remains intact.
For chipmakers like Nvidia and Micron, the premarket gains are a small sign of stability after a rough Thursday. But the AI trade has been volatile, with concerns about AI funding and wireless talk rattling markets. Investors will be watching to see if these stocks can hold their gains through the regular session.
Ultimately, the split among WallStreetBets favorites is a microcosm of the broader market: there's no single direction, and individual stories matter more than the overall tape. For investors, the lesson is to focus on the fundamentals and avoid getting caught up in short-term noise.
